H. Gilbert Welch | Academic Influence

H. Gilbert Welch's AcademicInfluence.com Rankings

H. Gilbert Welch

Medical

#1097

World Rank

#1397

Historical Rank

#342

USA Rank

Public Health

#212

World Rank

#221

Historical Rank

#59

USA Rank

medical Degrees

H. Gilbert Welch

Philosophy

#4829

World Rank

#7484

Historical Rank

#1345

USA Rank

Logic

#2205

World Rank

#3147

Historical Rank

#548

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

H. Gilbert Welch's Degrees

Doctorate Medicine University of Cincinnati
Masters Public Health University of Washington

Why Is H. Gilbert Welch Influential?

(Suggest an Edit or Addition)

According to Wikipedia, H. Gilbert Welch is an American academic physician and cancer researcher. He was an internist at the Veterans Administration Medical Center in White River Junction, Vermont, as well as a professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice. In September 2018, Welch resigned from Dartmouth College after a 20-month long research misconduct investigation at Dartmouth concluded he had committed plagiarism.

(See a Problem?)

H. Gilbert Welch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Increasing incidence of thyroid cancer in the United States, 1973-2002. (2006) (3121)
Hospital volume and surgical mortality in the United States. (2002) (2764)
Hospital Volume and Surgical Mortality in the United States (2002) (2054)
Overdiagnosis in cancer. (2010) (1436)
Current thyroid cancer trends in the United States. (2014) (1327)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. (2005) (1256)
The Role of Numeracy in Understanding the Benefit of Screening Mammography (1997) (1058)
Effect of three decades of screening mammography on breast-cancer incidence. (2012) (926)
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. (2009) (591)
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. (2009) (588)
Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. (1993) (524)
Enthusiasm for cancer screening in the United States (2004) (514)
Surgical mortality as an indicator of hospital quality: the problem with small sample size. (2004) (486)
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. (2016) (446)
Are increasing 5-year survival rates evidence of success against cancer? (2000) (434)
Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? (2010) (422)
Addressing overdiagnosis and overtreatment in cancer: a prescription for change. (2014) (414)
Statins and the Risk of Colorectal Cancer (2005) (403)
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews (1998) (374)
All-cause mortality in randomized trials of cancer screening. (2002) (365)
Language barriers in medicine in the United States. (1995) (364)
Population-Based Risk for Complications After Transthoracic Needle Lung Biopsy of a Pulmonary Nodule: An Analysis of Discharge Records (2011) (350)
Prudent strategies for elective red blood cell transfusion. (1992) (337)
Avoiding the unintended consequences of growth in medical care: how might more be worse? (1999) (299)
Estimating Treatment Benefits for the Elderly: The Effect of Competing Risks (1996) (292)
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence (2013) (289)
Survival of outpatients with Alzheimer-type dementia. (1990) (267)
Epidemiology of head and neck cancer in the United States (2006) (253)
The natural history of invasive breast cancers detected by screening mammography. (2008) (251)
Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials (2009) (237)
Skin biopsy rates and incidence of melanoma: population based ecological study (2005) (233)
Geographic variation in expenditures for physicians' services in the United States. (1993) (222)
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? (2001) (211)
Using Autopsy Series To Estimate the Disease Reservoir for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find? (1997) (204)
Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization. (1999) (196)
Quantifying the benefits and harms of screening mammography. (2014) (195)
Is language a barrier to the use of preventive services? (1997) (195)
Thyroid cancer survival in the United States: observational data from 1973 to 2005. (2010) (176)
South Korea's Thyroid-Cancer "Epidemic"--Turning the Tide. (2015) (174)
Breast Cancer Screening, Incidence, and Mortality Across US Counties. (2015) (173)
Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. (2007) (172)
US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. (2000) (168)
Colorectal Cancer on the Decline--Why Screening Can't Explain It All. (2016) (167)
Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. (2005) (164)
The increasing incidence of small thyroid cancers: Where are the cases coming from? (2010) (161)
Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics. (2015) (158)
The Cost-Effectiveness of Treating All Patients with Type 2 Diabetes with Angiotensin-Converting Enzyme Inhibitors (1999) (157)
Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. (1989) (156)
The frequency of Pap smear screening in the United States (2004) (154)
The Rapid Rise in Cutaneous Melanoma Diagnoses. (2021) (152)
A New Scale for Assessing Perceptions of Chance (2000) (146)
Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. (2011) (145)
Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. (1993) (136)
Screening for disease. (1997) (134)
Risk communication in clinical practice: putting cancer in context. (1999) (134)
Screening mammography--a long run for a short slide? (2010) (133)
Can Patients Interpret Health Information? An Assessment of the Medical Data Interpretation Test (2005) (123)
Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks (2006) (121)
Regional Variations in Health Care Intensity and Physician Perceptions of Quality of Care (2006) (120)
Women's Perceptions of Breast Cancer Risk (1999) (115)
The risk of death by age, sex, and smoking status in the United States: putting health risks in context. (2008) (112)
The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm (2007) (109)
US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey (2000) (107)
Cervical cancer screening among women without a cervix. (2004) (104)
Should I Be Tested for Cancer?: Maybe Not and Here's Why (2004) (101)
Current antibiotic therapy for isolated urinary tract infections in women. (2006) (98)
Epidemiologic Signatures in Cancer. (2019) (97)
The use of Medicare home health care services. (1996) (94)
A comparison of the educational costs and incomes of physicians and other professionals. (1994) (92)
Reconsidering Prostate Cancer Mortality - The Future of PSA Screening. (2020) (91)
Saving Thyroids - Overtreatment of Small Papillary Cancers. (2018) (84)
Celebrity endorsements of cancer screening. (2005) (80)
Medicare Services Provided by Cardiologists in the United States: 1999–2008 (2012) (79)
Dealing with Limited Resources (1988) (75)
Advertising by academic medical centers. (2005) (74)
Are deaths within 1 month of cancer-directed surgery attributed to cancer? (2002) (74)
The future of the Department of Veterans Affairs health care system. (1995) (73)
Likelihood that a woman with screen-detected breast cancer has had her "life saved" by that screening. (2011) (71)
Advance directives and the cost of terminal hospitalization. (1994) (70)
U.S. trends in CABG hospital volume: the effect of adding cardiac surgery programs. (2007) (69)
Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. (2007) (68)
Risk charts: putting cancer in context. (2002) (68)
Variation in the tendency of primary care physicians to intervene. (2005) (68)
Diagnostic testing following fecal occult blood screening in the elderly. (1999) (67)
Overdiagnosis and mammography screening (2009) (66)
Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims (2013) (64)
Diagnostic testing following screening mammography in the elderly. (1998) (64)
Women's understanding of the mammography screening debate. (2000) (62)
Using the Results of a Baseline and a Surveillance Colonoscopy to Predict Recurrent Adenomas With High-Risk Characteristics (2009) (62)
Physician profiling. An analysis of inpatient practice patterns in Florida and Oregon. (1994) (61)
Machine Learning and the Cancer-Diagnosis Problem - No Gold Standard. (2019) (56)
Could distance be a proxy for severity-of-illness? A comparison of hospital costs in distant and local patients. (1993) (54)
Uncertainties in genetic testing for chronic disease. (1998) (54)
Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers (2006) (53)
The Effectiveness of a Primer to Help People Understand Risk (2007) (53)
Income and Cancer Overdiagnosis - When Too Much Care Is Harmful. (2017) (52)
The value of benefit data in direct-to-consumer drug ads. (2004) (52)
British Columbia sends patients to Seattle for coronary artery surgery. Bypassing the queue in Canada. (1991) (52)
The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography. (2008) (49)
Women’s Views on Breast Cancer Risk and Screening Mammography (2001) (49)
Prioritizing Oregon's hospital resources. An example based on variations in discretionary medical utilization. (1992) (49)
Repeat testing among Medicare beneficiaries. (2012) (48)
Patients and medical statistics. Interest, confidence, and ability. (2005) (48)
Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer (2002) (47)
Setting the revisit interval in primary care (1999) (46)
The zero mortality paradox in surgery. (2006) (46)
New diagnostic tests: more harm than good (2017) (43)
Readmission after surgery in Washington State rural hospitals. (1992) (42)
Who’s in charge here? (2007) (40)
Overdiagnosed: Making People Sick in the Pursuit of Health (2011) (36)
Patients and medical statistics (2005) (35)
Racial disparities in abdominal aortic aneurysm repair among male Medicare beneficiaries. (2008) (35)
Discounting in Cost-Effectiveness Analysis of Healthcare Programmes (1993) (34)
Cancer Screening, Overdiagnosis, and Regulatory Capture. (2017) (34)
Population-based risk of complications following transthoracic needle lung biopsy of a pulmonary nodule (2011) (33)
Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women (2022) (33)
Flawed inferences about screening mammography's benefit based on observational data. (2009) (32)
Teaching Evidence‐based Medicine: Caveats and Challenges (2000) (32)
Dealing with limited resources. The Oregon decision to curtail funding for organ transplantation. (1988) (31)
Preparing Manuscripts for Submission to Medical Journals: The Paper Trail (1999) (30)
Should the health care forest be selectively thinned by physicians or clear cut by payers? (1991) (28)
Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors (2018) (27)
Telephone care as an adjunct to routine medical follow-up. A negative randomized trial. (2000) (26)
Trends in diagnostic testing following a national guideline for evaluation of dyspepsia. (1996) (25)
Repeated Upper Endoscopy in the Medicare Population (2014) (24)
Why estimates of physician supply and requirements disagree. (1993) (24)
Health care tickets for the uninsured. (1989) (24)
What's Making Us Sick Is an Epidemic of Diagnoses (2007) (23)
Implications of expanding disease definitions: the case of osteoporosis. (2007) (22)
Case-mix adjustment: making bad apples look good. (1995) (22)
Informed choice in cancer screening. (2001) (21)
Physician relations in Canada: shooting inward as the circle closes. (1997) (19)
The impact of practicing in multiple hospitals on physician profiles. (1996) (18)
The heterogeneity of cancer (2018) (17)
Rapid estimation of hospital charges in patients with leukemia. Validation of a multivariate prediction model. (1989) (16)
Patients requiring at least five admissions in 1 year. Data from Washington State. (1991) (15)
Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19 (2021) (14)
Views on Breast Cancer Risk Patient-centered Decision Making Women ’ s Views on Breast Cancer Risk and Screening Mammography : A Qualitative Interview Study (2001) (14)
Know Your Chances (2008) (13)
Fee-for-data: a strategy to open the HMO black box. (1995) (13)
Evaluating Randomized Trials of Screening (1997) (13)
Variation in Ultrasound Diagnostic Thresholds for Carotid Stenosis in the United States (2020) (13)
Determining Transition Probabilities from Mortality Rates and Autopsy Findings (1997) (12)
Right and Wrong Reasons To Be Screened (2004) (12)
Questions about the value of early intervention. (1996) (11)
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US. (2022) (11)
Group writing of letters to the editor as the goal of journal club. (2006) (10)
Tobacco money: up in smoke? (2002) (10)
Informed choice in cancer screening. (2013) (10)
The exaggerated relations between diet, body weight and mortality: the case for a categorical data approach (2005) (9)
Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature. (1995) (9)
Trends in Metastatic Breast and Prostate Cancer. (2016) (9)
Response: Re: All-Cause Mortality in Randomized Trials of Cancer Screening (2002) (9)
Effect of screening mammography on breast cancer incidence. (2013) (8)
Marrow transplantation, cost effectiveness analysis and setting limits. (1993) (8)
Search and destroy--the right cancer strategy for Europeans? (2005) (8)
Valuing clinical strategies early in their development. (1992) (8)
Insurance and the risk of ruptured appendix. (1995) (8)
A reader's guide to surgical decision analysis. (1997) (8)
Language Barriers in Medicine-Reply (1995) (7)
Correction: Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? (2010) (7)
A piece of my mind. Making the call. (2011) (7)
Responding to the challenge of overdiagnosis. (2015) (7)
Risk of breast cancer in carriers of BRCA gene mutations. (1997) (7)
Thyroid Cancer Survival in the United States (2010) (7)
Estimating the Impact of Adding C-Reactive Protein as a Criterion for Lipid Lowering Treatment in the United States (2007) (6)
Industry Payments to Physician Directors of National Cancer Institute-Designated Cancer Centers, 2015-2017. (2019) (6)
Reducing "unnecessary" antibiotic use in primary care: hard rules, soft calls. (2001) (6)
Health care tickets for the uninsured. First class, coach, or standby? (1989) (6)
All-cause mortality as the primary endpoint for the GRAIL/National Health Service England multi-cancer screening trial (2021) (4)
When should this patient be seen again? (1999) (4)
Not so silver lining. (2011) (4)
Marked Increase of Esophageal Adenocarcinoma Incidence (2005) (4)
Rationing surgery: rules or constraints? (1993) (4)
Tobacco money: up in smoke? (2002) (3)
Priorities in Oregon-Reply (1992) (3)
Let's make a deal. Negotiating a settlement between physicians and society. (1992) (3)
Practice profiles [2] (1994) (3)
A Markov model of early diagnosis. (1996) (3)
Could more health care lead to worse health? (1999) (3)
Finding and redefining disease. (1999) (3)
In Zambia: doing more with less. (1983) (3)
Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors (2018) (3)
Cancer Screening-The Good, the Bad, and the Ugly. (2022) (2)
The Future of the Department of Veterans Affairs-Reply (1995) (2)
Is this issue a mistake? (2000) (2)
MRI Screening in Women with Dense Breasts. (2020) (2)
Association of UV Radiation Exposure, Diagnostic Scrutiny, and Melanoma Incidence in US Counties. (2022) (2)
Removing the Thyroid From Images, Not From Patients. (2020) (2)
Davies and Welch draw unfounded conclusions about thyroid cancer from epidemiological data-reply. (2014) (2)
Repeated Upper Endoscopy in the Medicare PopulationA Retrospective Analysis (2014) (2)
Nifedipine--induced hepatitis. (1986) (2)
Who’s Behind the Numbers? (2008) (2)
Cost-effectiveness of colorectal cancer screening. (2001) (2)
Assessing competing risks in treating the elderly. (1996) (2)
Tobacco money: up in smoke? Authors' reply (2002) (2)
Antibiotic resistance. A new kind of epidemic. (1984) (2)
Changing incidence of thyroid cancer. Authors' reply (2006) (2)
Who's in charge here? Maximizing patient benefit and professional authority by physician limit setting. (1994) (1)
ASO Visual Abstract: Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19 (2021) (1)
COMMENTARY Risk Charts: Putting Cancer in Context (2002) (1)
Epidemiologic Signatures in Cancer. Reply. (2020) (1)
Disclose and Manage Conflicts of Interest at Cancer Centers-Reply. (2020) (1)
Ramifications of screening for breast cancer (2006) (1)
Rising Incidence of Cancer of the Small Intestine: Overdiagnosis & Better Diagnosis of Low-Lethality Disease (2022) (1)
S1968 Esophageal Adenocarcinoma Incidence – are We Reaching the PEAK? (2010) (1)
The Public's Enthusiasm for Cancer Screening [3] (multiple letters) (2004) (1)
Continuous Physiologic Monitoring: False Alarms and Overdiagnosis. (2018) (1)
Who is responsible for care given during the inpatient stay? A preliminary examination of attending and procedure physicians in Medicare's new data system. (1995) (1)
Book Review The Last Well Person: How to Stay Well Despite the Health-Care System By Nortin M. Hadler. 313 pp. Montreal, McGill-Queen's University Press, 2004. $29.95. 0-7735-2795-8 (2005) (1)
Should Recommendations for Cancer Screening Differentiate on Race? (2022) (1)
Epidemiology of Head and Neck Cancer in the U.S: Which Battles Are We Winning? (2005) (1)
What This Book is About (2008) (1)
The Rapid Rise in Cutaneous Melanoma Diagnoses. Reply. (2021) (1)
Melanoma Overdiagnosis Is Not the Key Problem-Reply. (2022) (1)
General Numeracy Test (2020) (0)
Medical Care: How Might More Be Worse? Avoiding the Unintended Consequences of Growth in (2009) (0)
Should We Screen Never-Smoking Asian Women for Lung Cancer Using Low-Dose Computed Tomography?-Reply. (2022) (0)
Cervical cancer screening among women without a cervix. Authors' reply (2004) (0)
Changing Incidence of Thyroid Cancer (2006) (0)
Endnote ... Presentation Guidelines (for) converting odds ratios (ORs) to relative risks (RRs). (2000) (0)
Survival after colorectal cancer in a screened vs unscreened population (2013) (0)
Industry Payments Unrelated to Research Made to Physicians Across Medical Specialties (2022) (0)
[Table], Find the line with a specific age and smoking status. The numbers in that row tell you how many out of 1,000 women in that group will die in the next 10 years from . . . (2008) (0)
The Effect of Treatment-Related Deaths and "Sticky" Diagnoses on Recorded Prostate Cancer Mortality (2020) (0)
[Table, Understanding Risk]. (2008) (0)
Short-term outcomes after colorectal cancer among the oldest old patients: A cross-national comparative study. (2011) (0)
Should physicians screen for mild thyroid failure? (1996) (0)
Microscopic Screening of Reduction Mammoplasties Risks Overdiagnosis. (2018) (0)
Whos in charge here (1994) (0)
Cost-effectiveness of screening for colorectal cancer. (2001) (0)
A Markov Model Diagnosis of Early (1996) (0)
Beware of Exaggerated Certainty (2008) (0)
Number Converter and Risk Charts (2008) (0)
Credible Sources of Health Statistics (2008) (0)
[Box], Learn More (2008) (0)
The Public's Enthusiasm for Cancer Screening—Reply (2004) (0)
984 Repeat Upper Endoscopy in the Medicare Population (2012) (0)
Melanoma Incidence by Sex, Indoor Tanning, and Body Site-Reply. (2023) (0)
[Table], Number Converter (2008) (0)
Queuing in Canada-Reply (1992) (0)
Uncoupling Diagnosis and Treatment of Incidentally Imaged Renal Masses-Reply. (2018) (0)
A, The chance of dying in the next 10 years (2008) (0)
Judging the Benefit of a Health Intervention (2008) (0)
Breast-Cancer Tumor Size and Screening Effectiveness. (2017) (0)
Does Risk Reduction Have Downsides (2008) (0)
Do the Benefits Outweigh the Downsides (2008) (0)
Putting Risk in Perspective (2008) (0)
Medicare Data: The Authors Respond (1996) (0)
What Is My Risk (2008) (0)
Abstract 5909: The role of overdiagnosis & better diagnosis of low-lethality disease in the rising incidence of cancer of the small intestine (2022) (0)
Beware of Exaggerated Importance (2008) (0)
Caregiving in Alzheimer dementia (Reply) (1991) (0)
STAT-Interest and -Confidence Scales (2019) (0)
Simple strategies, complex issues. (1999) (0)
Not All Benefits Are Equal (2008) (0)
Should medical journals be a private business or a public service? (2000) (0)
Practice Guidelines: The Authors Respond (2008) (0)
Risky business. (2000) (0)
[Table], The numbers in the chart tell you how many out of 1,000 women of various ages will die in the next 10 years from colon cancer. (2008) (0)
Developing a Healthy Skepticism (2008) (0)
[Table, About This Book]. (2008) (0)
Cervical cancer screening among women without a cervix [2] (multiple letters) (2004) (0)
Role of GEFs in Disease (2008) (0)
Cost effectiveness of bone marrow transplantation (Reply) (1990) (0)
Geographic Variation in Diagnosis Frequency andRiskofDeathAmongMedicareBeneficiaries (2011) (0)
Can I Reduce My Risk (2008) (0)
[Table], The numbers in the chart tell you how many out of 1,000 fifty-year-old women will die in the next 10 years from . . . (2008) (0)
Effekte des Mammografie-Screenings (2017) (0)
B, The chance of not dying in the next 10 years (2008) (0)
Why Are Women More Likely to Be Overdiagnosed With Lung Cancer? (2023) (0)
Colorectal Cancer on the Decline. (2016) (0)
Consider the Downsides (2008) (0)
Response: Re: Overdiagnosis in Cancer (2010) (0)
MORE HEALTH CARE LEAD TO WORSE HEALTH (1999) (0)
RESPONSE: Re: Risk Charts: Putting Cancer in Context (2002) (0)
Thyroid Cancer in the U.S.: Are All Detected Cancers Important? (2005) (0)
Do better treatments save money? (Or do they just produce more patients?). (1999) (0)
CAREGIVING IN ALZHEIMER DEMENTIA. AUTHOR'S REPLY (1991) (0)
Number fifteen. (2001) (0)
Oregon's priority list--pertinence to radiologists. (1992) (0)

This paper list is powered by the following services:

Other Resources About H. Gilbert Welch

en.wikipedia.org

What Schools Are Affiliated With H. Gilbert Welch?

H. Gilbert Welch is affiliated with the following schools:

Image Attributions

Image Source for H. Gilbert Welch